Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
Medios AG stock (symbol: ILM1.DE) underwent a total of 1 stock splits.
The most recent stock split occured on Jul 19, 2012.
Date | Splite | Multiple |
---|---|---|
2012-07-19 | 1:4 | 1 |